Quick Answer
SINOVAC BIOTECH LTD reported Operating Income Loss of -$603.02 million for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -29.4% in Operating Income Loss from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2009 to 2023 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2009 to 2023), SINOVAC BIOTECH LTD's Operating Income Loss has declined by 1,530.7%.
- Historical annual values: Fiscal year 2023: -$603.02 million | Fiscal year 2022: -$466.07 million | Fiscal year 2021: $17.55 billion | Fiscal year 2020: $215.64 million | Fiscal year 2019: $68.56 million | Fiscal year 2018: $45.32 million | Fiscal year 2017: $45.42 million | Fiscal year 2016: $504.0 thousand | Fiscal year 2015: $3.70 million | Fiscal year 2014: $1.89 million | Fiscal year 2013: $9.95 million | Fiscal year 2012: -$21.15 million | Fiscal year 2011: $3.37 million | Fiscal year 2010: -$12.12 million | Fiscal year 2009: $42.15 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: